Blog

A 2025 landmark multi-clinic study analysing over a decade of egg freezing outcomes has provided the clearest data yet on how age at the time of freezing affects eventual live birth rates, finding a steep decline in usable outcomes for eggs frozen after age 38, and reinforcing that earlier freezing — ideally before 35 — produces substantially better long-term reproductive outcomes. As social and medical egg freezing services continue to expand rapidly across Dubai’s fertility clinics, driven by a growing professional female population choosing to delay childbearing for career, personal, or relationship reasons, clear data on how timing affects ultimate outcomes has become one of the most frequently requested pieces of information during initial fertility preservation consultations. What the Study Found Researchers tracked outcomes for women who later used their frozen eggs, finding that women who froze their eggs before age 35 achieved live birth rates per egg significantly higher than those who froze after 38, driven primarily by the well-established decline in egg quality and chromosomal normality that accelerates through the late thirties. Why Egg Quantity Alone Is Not Sufficient The study highlighted that egg quantity retrieved during a freezing cycle does not fully compensate for declining egg quality with age — meaning that even women who freeze a relatively high number of eggs in their late thirties may still face lower overall success rates than younger women who freeze fewer eggs, because a higher proportion of older eggs carry chromosomal abnormalities. Relevance for Women in Dubai Considering Fertility Preservation Social and medical egg freezing has become increasingly accessible and socially normalised across Dubai’s fertility clinics in Downtown Dubai, Business Bay, and beyond, often pursued by career-focused professional women planning to delay childbearing. This research provides important, concrete data to inform the timing decision for women considering this option. What This Means for Decision-Making This is not a suggestion that egg freezing after 35 is without value — many women in this age group still achieve successful pregnancies using frozen eggs. Rather, the research supports earlier consideration of fertility preservation for women who anticipate delaying childbearing, alongside a realistic, individualised discussion with a fertility specialist about expected outcomes based on current age and ovarian reserve testing. Implications for Fertility Counseling This research also has implications for how fertility clinics counsel women at the point of consultation, with many specialists now placing greater emphasis on early, proactive discussion of fertility preservation timing — sometimes well before a woman feels she is actively facing this decision. For women in Dubai’s career-focused professional community who may not yet feel ready to start a family but want to preserve future options, this data supports having that exploratory conversation with a fertility specialist sooner rather than later, simply to understand personal ovarian reserve and realistic timelines. How This Compares to Current Standard Practice in Dubai Egg freezing services are well established and increasingly popular across Dubai’s fertility clinics, reflecting broader regional trends toward delayed childbearing among professional women. This research provides valuable, concrete data to support more informed timing decisions within these already well-established services. Frequently Asked Questions Is it too late to freeze my eggs at 38? No, but this research suggests outcomes are generally less favourable than freezing earlier. An individualised fertility assessment, including ovarian reserve testing, will provide the most accurate picture of your specific situation. How many eggs should I aim to freeze? The appropriate number varies by age and individual fertility assessment. Your fertility specialist can provide a personalised estimate based on your ovarian reserve testing and age at the time of freezing. Does egg freezing guarantee a future pregnancy? No. Egg freezing significantly improves the odds of future pregnancy using younger eggs but does not guarantee a live birth, as outcomes still depend on egg and embryo quality, uterine factors, and other individual circumstances. Conclusion Fertility preservation decisions benefit enormously from clear, current data on how timing affects outcomes. Women in Dubai considering egg freezing should seek an individualised consultation with a fertility specialist to understand their own ovarian reserve and realistic expected outcomes at their current age. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Get personalised fertility preservation advice, ovarian reserve assessment, and evidence-based guidance to help you make informed reproductive choices. Contact Us

A 2025 randomised trial evaluating specific Lactobacillus-strain probiotics in postmenopausal women with a history of recurrent urinary tract infections has found a clinically meaningful reduction in infection recurrence over a 12-month period, offering a promising non-antibiotic preventive option for a condition that significantly affects quality of life for many women after menopause. Recurrent urinary tract infection is a genuinely common and often quietly endured concern among postmenopausal women, frequently treated with repeated antibiotic courses that themselves carry long-term concerns around resistance — making any additional, evidence-supported prevention option a meaningful development for women across Dubai’s menopause-focused clinics. Why Postmenopausal Women Are More Prone to Recurrent UTIs Declining oestrogen after menopause causes thinning of the vaginal and urethral tissue and a shift away from the protective Lactobacillus-dominant vaginal microbiome typical of reproductive years — both changes that increase susceptibility to recurrent urinary tract infections, a condition that falls under the broader genitourinary syndrome of menopause. What the New Research Found Women receiving a specific oral Lactobacillus probiotic formulation experienced significantly fewer UTI recurrences over the study period compared to a placebo group, with researchers proposing that restoration of a more protective vaginal and periurethral microbial environment reduces colonisation by UTI-causing bacteria such as E. coli. How This Complements Existing Treatment Vaginal oestrogen therapy remains a well-established, highly effective treatment for genitourinary syndrome of menopause, including recurrent UTI prevention, and this new probiotic research should be seen as a potential complementary option rather than a replacement, particularly valuable for women who prefer to avoid or cannot use topical oestrogen. Relevance for Women in Dubai Recurrent UTIs are a common and often distressing concern for postmenopausal women across Dubai, including in communities such as Jumeirah and Bur Dubai with significant populations of women in this life stage. This research adds a genuinely evidence-supported, low-risk option to the conversation around recurrent UTI prevention beyond repeated antibiotic courses, which carry their own long-term concerns around resistance. Where This Research May Go Next Researchers in this field are also exploring whether different probiotic strains or delivery methods, including vaginal rather than oral probiotic formulations, might offer even greater benefit, suggesting this area of research is likely to continue evolving over the coming years. Women interested in this approach should look for products using the specific, clinically studied Lactobacillus strains referenced in trial literature, since not all commercially available probiotics have been evaluated for this specific use. How This Compares to Current Standard Practice in Dubai Vaginal oestrogen remains the established first-line approach for recurrent UTI prevention in postmenopausal women across Dubai’s specialist clinics, with probiotic approaches representing an emerging complementary option still gaining wider clinical familiarity. Frequently Asked Questions Can probiotics replace antibiotics for treating an active UTI? No. This research relates to prevention of recurrence, not treatment of an active infection, which still requires appropriate antibiotic therapy guided by urine culture results. Is vaginal oestrogen still the best treatment for recurrent UTIs after menopause? Vaginal oestrogen remains a well-established, highly effective first-line option. Probiotics represent an emerging complementary or alternative approach, particularly for women unable or unwilling to use topical oestrogen. Are there side effects to taking probiotics for UTI prevention? Generally, oral probiotics are well tolerated with a low side effect profile, though mild digestive symptoms are occasionally reported. Discuss any new supplement with your doctor, particularly if you have other health conditions. Conclusion Expanding the toolkit for managing recurrent UTIs in postmenopausal women reduces reliance on repeated antibiotic courses. Dr. Ruby Rashmi discusses the full range of evidence-based prevention options, including emerging research, with every patient experiencing this common menopausal concern. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Receive personalised care for recurrent urinary tract infections, menopause-related health concerns, and evidence-based prevention strategies tailored to your individual needs. Contact Us

An updated 2025 systematic review pooling data across multiple countries has reaffirmed that long-acting reversible contraception — specifically the contraceptive implant and intrauterine devices — produces significantly lower unintended pregnancy rates among adolescents and young women compared to short-acting methods such as the pill, primarily due to its independence from daily user adherence. Given that unintended adolescent pregnancy carries significant social, educational, and health implications, ensuring that the most effective contraceptive information reaches young women and their families — across every community in Dubai, from Jumeirah to Mankhool — remains an important public health priority that this research helps to reinforce with clear, current data. What the Review Found The 2025 analysis found failure rates for LARC methods among adolescents to be consistently below 1%, compared to failure rates of 5 to 9% for short-acting hormonal methods such as the combined pill when used under typical real-world conditions, where missed doses and inconsistent use are common, particularly among younger users. Why This Distinction Matters Clinically The dramatic difference between LARC and short-acting method failure rates in real-world use is driven almost entirely by user-dependent factors — LARC methods, once correctly placed, require no daily action, removing the most common source of contraceptive failure among adolescents and young adults specifically. Addressing Outdated Concerns This updated evidence continues to dismantle outdated clinical hesitancy around offering IUDs to adolescents and nulliparous young women, a historical concern not supported by current research. Modern, smaller-profile IUDs are specifically designed to be suitable for this population, and major bodies including ACOG now explicitly recommend LARC as a first-line option for adolescent contraception where appropriate. What This Means for Families in Dubai For families across Dubai navigating conversations about contraception for older adolescent daughters — whether for pregnancy prevention, menstrual symptom management, or both — this research supports an open, non-judgemental discussion of the full range of contraceptive options, including LARC methods, rather than defaulting only to short-acting options. An Additional Clinical Benefit Worth Considering This evidence also has implications beyond contraceptive effectiveness alone — LARC methods, particularly the hormonal IUS, frequently provide the additional benefit of significantly reduced menstrual bleeding and pain, addressing two clinical needs simultaneously for many adolescent patients who experience both contraceptive needs and troublesome periods. This dual benefit is often a meaningful consideration in family discussions about which method best fits a young patient’s overall needs, beyond pregnancy prevention alone. How This Compares to Current Standard Practice in Dubai Adolescent contraceptive counseling across Dubai increasingly reflects international guidance favouring LARC discussion alongside traditional options, supported by growing comfort among specialists in offering IUDs and implants to younger, nulliparous patients. Frequently Asked Questions Are IUDs safe for teenagers who have never had children? Yes. Current evidence and major guideline bodies confirm IUDs are safe and appropriate for adolescents and nulliparous young women, with smaller-profile devices specifically designed for this population. Does using a LARC method affect future fertility? No. Fertility returns promptly after removal of LARC methods, with no evidence of impaired long-term fertility in adolescents or adults. At what age can my daughter get an IUD in Dubai? There is no strict age cutoff; suitability is assessed based on individual clinical factors rather than age alone. Discuss this directly with a gynaecologist experienced in adolescent care. Conclusion Contraceptive counseling for adolescents should reflect the strongest current evidence on effectiveness. Dr. Ruby Rashmi provides comprehensive, non-judgemental contraceptive counseling for young patients and their families as part of her Dubai practice. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Receive personalised adolescent gynaecology care, confidential contraceptive counselling, and evidence-based reproductive health guidance for young women and their families. Contact Us

New 2025 cohort data has strengthened the case for choline supplementation alongside the well-established folic acid recommendation in early pregnancy, finding that children born to mothers with higher combined folate and choline intake during the first trimester showed measurably better scores on standardised early childhood cognitive assessments at age four. As prenatal nutrition science continues to identify the specific contribution of individual nutrients beyond the well-established basics, expectant mothers across Dubai have an increasing amount of detailed, evidence-based guidance available to optimise their pregnancy nutrition — provided they have access to a specialist who stays current with this evolving research. Why Choline Has Received Less Attention Than Folic Acid While folic acid supplementation has been a cornerstone of pregnancy nutrition guidance for decades due to its well-established role in preventing neural tube defects, choline — another nutrient critical for fetal brain development — has historically received far less public and clinical attention, despite many pregnant women’s dietary choline intake falling below recommended levels. What the New Research Found The 2025 study found that children of mothers with combined high folate and high choline intake during early pregnancy scored significantly higher on measures of memory and attention at age four compared to children of mothers with adequate folate but lower choline intake, suggesting choline may provide an additional, independent neurodevelopmental benefit beyond folic acid alone. What This Means for Pregnant Women in Dubai Choline is found in eggs, meat, fish, and to a lesser extent in some plant sources, but many standard prenatal vitamins contain only minimal choline content. Women across Dubai planning pregnancy or in early pregnancy should discuss their dietary choline intake with their obstetrician, particularly women following vegetarian or vegan diets who may have lower baseline intake. Practical Recommendations Current general guidance suggests an intake of approximately 450mg of choline daily during pregnancy. Rather than universally recommending high-dose supplementation based on this single study, the most practical current advice is dietary review and, where appropriate, supplementation guided by your obstetrician based on your individual dietary pattern. Guidance for Specific Dietary Patterns Women following specific dietary patterns, including vegetarian, vegan, or other restricted diets, may have particular value in discussing choline intake directly with their obstetrician or a registered dietitian, since plant-based choline sources are generally less concentrated than animal-based sources such as eggs and meat. This makes individualised dietary assessment, rather than a universal supplementation recommendation, the most appropriate current approach while further research continues to refine optimal intake targets. How This Compares to Current Standard Practice in Dubai Standard antenatal nutritional counseling across Dubai’s obstetric practices has historically centred on folic acid, iron, and vitamin D, with choline receiving comparatively less routine attention. This research supports broadening that standard nutritional conversation. Frequently Asked Questions Should I take a choline supplement during pregnancy? Discuss your dietary choline intake with your obstetrician. If your diet is low in choline-rich foods such as eggs and meat, supplementation may be recommended alongside your standard folic acid intake. Is choline as important as folic acid in pregnancy? Folic acid remains essential and well-established for neural tube defect prevention. Choline is increasingly recognised as an important complementary nutrient for fetal brain development, though the evidence base, while growing, is not yet as extensive as that for folic acid. What foods are good sources of choline? Eggs (particularly the yolk), beef, chicken, fish, and to a lesser degree some cruciferous vegetables and legumes are good dietary sources of choline. Conclusion Pregnancy nutrition guidance continues to evolve as research identifies additional nutrients relevant to fetal development. Women in Dubai should discuss comprehensive antenatal nutrition, including choline intake, with their obstetrician early in pregnancy. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Receive personalised antenatal nutrition guidance, evidence-based pregnancy care, and expert advice to support a healthy pregnancy for you and your baby. Contact Us

A 2025 randomised controlled trial has demonstrated that a structured 12-week resistance training programme reduced self-reported menopausal joint pain by an average of 40%, offering a meaningful, non-pharmacological option for one of menopause’s most underrecognised and undertreated symptoms. As menopause care increasingly moves beyond simple hormone discussion toward comprehensive lifestyle medicine, this kind of targeted exercise research offers women across Dubai’s well-developed fitness and wellness infrastructure a genuinely evidence-based way to take an active role in managing one of menopause’s most physically limiting symptoms. Why Joint Pain Is an Underappreciated Menopause Symptom While hot flashes and mood changes dominate public conversation about menopause, joint and muscle aches affect a substantial proportion of women during this transition, driven by the role oestrogen plays in maintaining cartilage health and modulating inflammatory processes within joints. Despite its prevalence, this symptom is frequently dismissed as unrelated ageing rather than recognised as a treatable component of the menopause transition. What the Research Found Women in the trial who completed a structured resistance training programme, performed twice weekly and supervised by a qualified trainer, reported significantly reduced joint pain scores compared to a control group, alongside measurable improvements in muscle mass and functional strength — addressing both the symptom and the underlying age-related muscle loss that compounds it. Relevance for Women in Dubai Dubai’s extensive fitness infrastructure, including women-only gyms and studios across Dubai Design District, Al Seef, and throughout the city, makes structured exercise interventions like this genuinely accessible for many women navigating menopause. This research provides a clear, evidence-based rationale for incorporating resistance training specifically — rather than only walking or cardio — into a menopause wellness plan. How This Fits Alongside Other Menopause Treatments Resistance training should be viewed as a complementary intervention rather than a replacement for HRT or other medical treatment where indicated, particularly for women with significant vasomotor symptoms. However, for joint pain specifically, this research suggests targeted strength training may offer benefits that pharmacological treatment alone does not fully address. A Broader Principle for Menopause Exercise This research also reinforces a broader principle increasingly recognised in menopause care: that exercise prescription should be specific to the symptom being targeted, rather than relying on generic advice to simply ‘stay active.’ Cardiovascular exercise, resistance training, and flexibility work each appear to offer somewhat different benefit profiles across the range of menopausal symptoms, suggesting that a well-rounded menopause exercise plan may need to incorporate more than one type of activity to address the full spectrum of physical changes this transition can bring. How This Compares to Current Standard Practice in Dubai Exercise guidance within standard menopause consultations across Dubai has traditionally focused on general activity recommendations rather than symptom-specific exercise prescription. This research supports a more targeted approach, particularly for women reporting joint pain as a primary concern. Frequently Asked Questions Can exercise alone treat menopausal joint pain? This research suggests structured resistance training can meaningfully reduce joint pain severity, though it should be considered alongside, not necessarily instead of, other appropriate menopause treatments depending on your overall symptom profile. How often should I do strength training for menopause symptoms? The trial protocol used twice-weekly supervised sessions over 12 weeks, suggesting a similar frequency and duration may be needed to see comparable benefit. Can I do strength training at home rather than at a gym? Yes, provided the exercises are performed with correct form and adequate resistance. Many women benefit from at least an initial session with a qualified trainer to ensure safe and effective technique, particularly when starting a new programme during menopause. Conclusion Exercise prescription is increasingly recognised as a genuine, evidence-based component of comprehensive menopause care. Dr. Ruby Rashmi incorporates lifestyle and exercise guidance alongside medical treatment options in every menopause consultation in her Dubai practice. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Receive personalised menopause care with evidence-based lifestyle guidance, exercise recommendations, and advanced treatment options tailored to your needs. Contact Us

A 2025 large-scale population study has provided strong supporting evidence for universal cervical length screening at the time of the standard 20-week anomaly scan, finding that systematic screening — rather than screening only women with known risk factors — identified a substantial proportion of women who went on to benefit from preventive intervention but who would not have been flagged by risk-factor-based screening alone. Preterm birth remains one of the leading contributors to neonatal complications worldwide, making any evidence-supported addition to its prevention strategy — particularly one as low-cost and low-risk as an additional ultrasound measurement during an already-scheduled scan — a development worth understanding for every pregnant woman across Dubai’s antenatal care network. Why Cervical Length Matters in Pregnancy A shortened cervix in the second trimester is one of the strongest predictors of spontaneous preterm birth. Identifying this finding early allows for interventions — including vaginal progesterone, cervical cerclage, or simply closer monitoring — that have been shown in multiple trials to meaningfully reduce preterm birth rates in appropriately selected women. What the New Research Found The 2025 study compared outcomes between population-wide cervical length screening at the 20-week scan versus screening only women with traditional risk factors such as previous preterm birth. Universal screening identified a significant number of at-risk women with no prior risk factors at all, who subsequently benefited from preventive treatment and avoided preterm delivery. Relevance for Antenatal Care in Dubai This research supports incorporating cervical length measurement as a routine, low-cost addition to the already comprehensive 20-week anomaly scan that most pregnant women across Dubai — including those receiving care in Bur Dubai and Business Bay — already attend. The measurement adds only a few minutes to a scan most women are having regardless. What to Ask at Your 20-Week Scan Pregnant women in Dubai should feel comfortable asking their sonographer or obstetrician whether cervical length assessment is included as part of their anomaly scan, particularly given this growing body of evidence supporting its value even for women without traditional preterm birth risk factors. Practical Considerations for Implementation Implementing universal cervical length screening does have practical implications for ultrasound departments, including additional scanning time and sonographer training requirements, which partly explains why adoption has been gradual even as the supporting evidence has strengthened. Women in Dubai are encouraged to have this conversation directly with their antenatal care provider, since practice can vary between different hospitals and clinics even within the same city. How This Compares to Current Standard Practice in Dubai Practice regarding routine cervical length screening at the 20-week scan currently varies between providers across Dubai, with some specialist centres already incorporating it as standard and others reserving it for women with known risk factors. Frequently Asked Questions Is cervical length screening painful or risky? No. It is performed using the same transvaginal or transabdominal ultrasound probe already used for the anomaly scan and adds no additional risk to the pregnancy. What happens if my cervix is found to be short? Depending on the degree of shortening and your individual risk profile, your obstetrician may recommend vaginal progesterone, cervical cerclage, increased monitoring frequency, or activity modification. Will my clinic in Dubai automatically include cervical length measurement in my 20-week scan? Practice varies between providers. It is reasonable to specifically ask your sonographer or obstetrician whether this measurement is included as part of your scan. Conclusion Universal cervical length screening represents a simple, evidence-supported addition to routine antenatal care that may help identify and prevent preterm birth in women who would otherwise go unrecognised. Women in Dubai should discuss this option with their obstetrician at their 20-week scan. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Receive personalised antenatal care, advanced pregnancy screening, and evidence-based management to support a healthy pregnancy journey. Contact Us

Real-world effectiveness data published in 2025, following fezolinetant’s regulatory approval as the first neurokinin-3 receptor antagonist for menopausal vasomotor symptoms, has confirmed the strong efficacy seen in earlier clinical trials now translates effectively into routine clinical practice, offering women a genuinely new non-hormonal option for managing hot flashes and night sweats. The arrival of a genuinely effective non-hormonal option represents a significant development for the substantial proportion of women globally, and across Dubai specifically, who either cannot use HRT due to medical contraindications or simply prefer to avoid hormonal treatment, a group that has historically had access to comparatively limited and often less effective alternatives. What Fezolinetant Is and How It Works Fezolinetant works through an entirely different mechanism than previous non-hormonal options such as SSRIs or gabapentin. It directly targets the neurokinin-3 receptor pathway in the brain’s thermoregulatory centre — the same pathway disrupted by oestrogen withdrawal during menopause — to reduce the frequency and severity of hot flashes without involving hormones at all. What the 2025 Real-World Data Shows The new data, drawn from over 5,000 women treated in routine clinical settings rather than controlled trial conditions, confirmed reductions in hot flash frequency and severity consistent with the original pivotal trials, alongside good tolerability and a low discontinuation rate due to side effects. Who This Option Is Particularly Relevant For This medication is especially valuable for women who cannot or prefer not to use hormone replacement therapy — including women with a history of hormone-receptor-positive breast cancer, certain clotting disorders, or simply a strong personal preference to avoid hormonal treatment. For these women across World Trade Centre, Jumeirah, and the wider Dubai community, previous non-hormonal options often provided only partial relief. What to Discuss With Your Specialist Women experiencing significant vasomotor symptoms who are not candidates for, or who prefer to avoid, HRT should discuss fezolinetant as a specific, evidence-backed treatment option with their menopause specialist, alongside a full review of liver function testing requirements, which are part of the standard monitoring protocol for this medication. What to Discuss With Your Specialist As with any newly approved medication, ongoing post-marketing surveillance continues to refine understanding of fezolinetant’s long-term safety profile, including the liver function monitoring that is currently recommended during treatment. Women considering this option should expect their specialist to discuss this monitoring requirement clearly, along with realistic expectations about the degree of symptom improvement typically achieved, which — while substantial for many women — does not always match the symptom elimination some women experience with HRT. How This Compares to Current Standard Practice in Dubai Non-hormonal menopause treatment options are increasingly discussed across Dubai’s menopause-focused clinics, particularly for women with contraindications to HRT. As fezolinetant becomes more widely available regionally, it is expected to become a standard part of this non-hormonal discussion. Frequently Asked Questions Is fezolinetant a hormone? No. It works through a non-hormonal mechanism targeting the brain’s thermoregulatory pathway, making it a genuine option for women who cannot or prefer not to take HRT. Is fezolinetant available for menopause treatment in Dubai? Availability is expanding across UAE healthcare providers following international approval. Discuss current availability and suitability with your menopause specialist. How does fezolinetant compare in effectiveness to HRT for hot flashes? Clinical trial data suggests fezolinetant provides substantial symptom reduction, though for many women HRT remains the most effective option overall. The right choice depends on individual eligibility, preference, and symptom severity. Conclusion The expanding range of effective non-hormonal menopause treatments means more women than ever can find meaningful symptom relief, regardless of their suitability for HRT. Dr. Ruby Rashmi keeps pace with these emerging options to provide every patient in Dubai with the full range of evidence-based menopause care. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Explore personalised menopause care with the latest evidence-based hormonal and non-hormonal treatment options tailored to your needs. Contact Us

A 2025 prospective study following women undergoing IVF treatment has found a clear, statistically significant association between pre-treatment sleep quality and treatment outcomes, with women reporting poor sleep in the months preceding their cycle showing notably lower live birth rates than those with good sleep quality, even after controlling for age and ovarian reserve. For the substantial number of women across Dubai’s fertility clinics in Business Bay, Downtown Dubai, and beyond who already juggle demanding professional schedules with the physical and emotional intensity of fertility treatment, this research adds sleep to an already long list of factors competing for attention — making clear, practical guidance from a trusted specialist all the more valuable. What the Study Measured Researchers used validated sleep quality questionnaires alongside objective actigraphy (wrist-worn sleep tracking) in the three months before IVF treatment, finding that women in the poorest sleep quality quartile had significantly lower oocyte yield, embryo quality scores, and ultimately live birth rates compared to women with good sleep quality. Why Sleep May Affect Fertility Outcomes The proposed mechanisms include sleep’s well-established role in regulating cortisol and other stress hormones, its impact on insulin sensitivity and metabolic health, and its influence on melatonin — a hormone with documented antioxidant effects within the ovarian follicle that may protect oocyte quality. Relevance for Women in Dubai Preparing for Fertility Treatment Dubai’s fast-paced professional environment, frequent travel across time zones, and the common pattern of long working hours can all meaningfully disrupt sleep quality for many women in the months before pursuing fertility treatment in Business Bay, Downtown Dubai, and across the city’s fertility clinics. This research adds sleep optimisation to the established list of pre-IVF lifestyle factors worth addressing. Practical Implications for Treatment Preparation While this research does not suggest sleep alone determines IVF success — ovarian reserve, age, and underlying fertility diagnosis remain the dominant factors — it supports incorporating sleep hygiene assessment and, where needed, targeted intervention into comprehensive pre-IVF preparation alongside nutrition, weight optimisation, and stress management. Putting This Research Into Context This research also fits into a broader and increasingly well-evidenced pattern within fertility medicine: a growing recognition that IVF outcomes are influenced by a wider range of modifiable lifestyle factors than was appreciated even five years ago, including nutrition, stress, environmental exposures, and now sleep. For women in Dubai juggling demanding careers with fertility treatment, this expanding evidence base offers both an opportunity and, sometimes, an additional source of pressure — a reminder that comprehensive fertility preparation works best when guided by a specialist who can help prioritise which factors matter most for an individual case, rather than attempting to optimise everything simultaneously. How This Compares to Current Standard Practice in Dubai Pre-IVF preparation counseling across Dubai’s fertility clinics already typically addresses nutrition, weight, and stress management. This research supports more deliberate inclusion of sleep assessment as a standard component of that broader preparation conversation. Frequently Asked Questions Can poor sleep alone cause infertility? No single factor in isolation typically causes infertility, but this research suggests sleep quality is a meaningful, modifiable factor that may influence IVF treatment outcomes alongside other established variables. How much sleep should I aim for before starting IVF treatment? While specific thresholds vary by individual, the study associated consistently poor sleep quality — rather than a single specific number of hours — with worse outcomes, supporting a general focus on sleep hygiene and consistency in the months before treatment. What practical steps can I take to improve sleep before starting IVF? Consistent sleep and wake times, reducing screen exposure before bed, limiting caffeine in the afternoon and evening, and addressing any underlying sleep disorders are reasonable starting points to discuss with your fertility team. Conclusion Fertility treatment preparation continues to expand beyond purely medical interventions to encompass broader lifestyle optimisation. Women preparing for IVF in Dubai should discuss comprehensive preparation, including sleep health, with their fertility specialist well in advance of starting treatment. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Receive personalised fertility counselling, IVF preparation guidance, and evidence-based reproductive care designed to optimise your treatment journey. Contact Us

An updated 2025 WHO position paper has reinforced and sharpened existing guidance on HPV vaccination timing, presenting new data confirming that vaccination at ages 9 to 12 produces a measurably stronger and more durable immune response than vaccination administered in the later teenage years, even though both timings provide substantial protection against future cervical cancer. Given that HPV-related cervical cancer remains one of the most preventable cancers affecting women worldwide, ensuring vaccination occurs at the scientifically optimal age represents one of the highest-value, lowest-cost interventions available in modern preventive women’s healthcare — a message worth reinforcing clearly for every family across Dubai navigating their child’s vaccination schedule. What the Updated Guidance Confirms The 2025 update draws on long-term immunogenicity data showing that the antibody response generated by HPV vaccination administered before age 13 is significantly higher and more durable than that generated by vaccination given between ages 15 and 18, even when using the same two-dose schedule recommended for younger adolescents. Why Earlier Vaccination Produces a Stronger Response Researchers attribute this difference to the more robust adaptive immune response typical of pre-adolescent immune systems. This is the underlying scientific basis for WHO’s continued recommendation that vaccination occur well before the typical age of sexual debut, maximising both immune response and the window of protection before any potential HPV exposure. What This Means for Parents in Dubai For parents across Dubai — including the family-dense communities of Jumeirah and the medically engaged population around Dubai Healthcare City — this update reinforces the importance of discussing HPV vaccination with a gynaecologist or paediatrician at the earliest recommended age, rather than waiting until the later teenage years when a young woman might attend her first gynaecological consultation. Addressing Common Parental Concerns Some parents understandably feel that discussing HPV vaccination at age 9 to 12 is premature, given that it is a vaccine against a sexually transmitted infection. The clinical rationale, however, is entirely about immune response timing and ensuring protection is firmly established well before any possible future exposure — not an assumption about a child’s current or near-term behaviour. How to Frame This Conversation as a Parent Parents weighing this decision often find it helpful to think of HPV vaccination in the same category as other routine childhood immunisations administered well before any relevant exposure risk arises, rather than viewing it as a conversation specifically about a child’s future behaviour. Framing the vaccination this way — as preventive healthcare administered at the scientifically optimal time for immune response — tends to align more comfortably with how most parents already think about other vaccines on the standard immunisation schedule. How This Compares to Current Standard Practice in Dubai HPV vaccination is available across UAE healthcare providers and increasingly promoted through school health programmes. This updated guidance reinforces existing efforts to encourage vaccination at the optimal younger age rather than introducing a new policy direction. Frequently Asked Questions What is the ideal age to vaccinate against HPV according to the 2025 update? WHO continues to recommend vaccination at ages 9 to 12 for the strongest and most durable immune response, though catch-up vaccination remains valuable and effective up to age 26. Is it too late to vaccinate my teenage daughter against HPV? No. While the immune response is strongest when vaccination occurs before age 13, vaccination remains effective and worthwhile through the teenage years and into the mid-twenties. Is the HPV vaccine mandatory for school enrolment in Dubai? Vaccination policies vary by school and emirate. Check current requirements with your child’s school or paediatrician, while discussing the clinical timing benefits with your gynaecologist or paediatric specialist regardless of any policy requirement. Conclusion Early, well-timed HPV vaccination remains one of the most powerful tools available for long-term cervical cancer prevention. Dr. Ruby Rashmi provides HPV vaccination guidance for young patients and their families as part of her adolescent gynaecology practice in Dubai. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Get expert guidance on HPV vaccination, adolescent gynaecology, cervical cancer prevention, and personalised women’s healthcare. Contact Us

A 2025 dietary intervention study has found that women following a Mediterranean dietary pattern — rich in vegetables, olive oil, fish, and whole grains, with limited processed foods — experienced significantly reduced heavy menstrual bleeding severity over a six-month period compared to a control group following their usual diet, adding nutrition to the evidence-based toolkit for managing this common condition. This finding adds a valuable, accessible dimension to menstrual health management at a time when many women are already seeking lifestyle-based approaches to complement medical treatment, and it sits comfortably alongside Dubai’s increasingly health-conscious food culture and the wide availability of fresh, high-quality Mediterranean-style ingredients across the city’s markets and restaurants. What the Research Found Participants following the Mediterranean dietary pattern showed a measurable reduction in self-reported menstrual blood loss and pictorial blood loss assessment chart scores, alongside reduced markers of systemic inflammation. Researchers propose that the anti-inflammatory properties of this dietary pattern may reduce the excessive prostaglandin activity associated with heavy and painful periods. Why This Adds to Existing Treatment Options Heavy menstrual bleeding is already effectively managed through options including the levonorgestrel intrauterine system, tranexamic acid, and NSAIDs. This new dietary evidence does not replace these established treatments but offers a complementary, low-risk lifestyle intervention that women can implement alongside medical management, or as a first step for milder symptoms. Relevance for Women in Dubai Dubai’s food environment — with its abundant fresh produce, fish, and increasingly health-conscious dining culture — makes Mediterranean-style eating genuinely achievable for many women across the city, from Mankhool to Al Seef. For women managing heavy periods who are interested in dietary approaches alongside their medical treatment, this research provides a credible, evidence-based direction. What This Doesn’t Replace It remains essential that heavy menstrual bleeding is properly investigated by a gynaecologist before relying on dietary changes alone, since heavy bleeding can signal underlying conditions such as fibroids, polyps, or adenomyosis that require specific medical or surgical treatment regardless of dietary pattern. Putting This Research Into Context It is also worth situating this finding within what is already known about diet and inflammation more broadly. The Mediterranean dietary pattern has an extensive evidence base across cardiovascular health, metabolic disease, and now menstrual health, largely attributed to its high content of monounsaturated fats, omega-3 fatty acids, and antioxidant-rich vegetables — all of which counter the inflammatory pathways implicated in excessive menstrual bleeding and pain. For women already managing other aspects of their health through diet, this research offers reassurance that the same eating pattern may offer gynaecological benefits as well. How This Compares to Current Standard Practice in Dubai Dietary counseling for menstrual disorders has historically received less structured attention within standard Dubai gynaecology consultations compared to pharmacological management. This research supports a more deliberate integration of nutritional guidance alongside medical treatment for women managing heavy or painful periods. Frequently Asked Questions Can diet alone treat heavy periods? Dietary changes such as a Mediterranean eating pattern may help reduce symptom severity, but heavy menstrual bleeding should always be properly investigated and managed medically, as dietary change alone does not address underlying structural causes. How quickly might dietary changes affect period symptoms? The 2025 study observed measurable improvement over a six-month period, suggesting dietary changes require sustained adherence to produce a noticeable effect. How long should I follow a Mediterranean diet to see an effect on my periods? The study observed measurable benefit over a six-month period of consistent adherence, suggesting this is a sustained lifestyle approach rather than a quick fix. Conclusion Lifestyle and dietary approaches continue to add valuable complementary options to established heavy menstrual bleeding treatments. Women in Dubai experiencing heavy periods should seek proper investigation first, with lifestyle measures incorporated as part of a comprehensive management plan. Sources & References This article references recently published research and evolving guidance from peer-reviewed journals and the following recognised authorities in women’s health, current as of the time of writing: Royal College of Obstetricians and Gynaecologists (RCOG) — rcog.org.uk American College of Obstetricians and Gynecologists (ACOG) — acog.org International Federation of Gynecology and Obstetrics (FIGO) — figo.org World Health Organization (WHO) — who.int National Institute for Health and Care Excellence (NICE, UK) — nice.org.uk American Society for Reproductive Medicine (ASRM) — asrm.org European Society of Human Reproduction and Embryology (ESHRE) — eshre.eu ⚠ IMPORTANT DISCLAIMER This article is provided for general knowledge and reference purposes only and summarises recent research findings. It is not a substitute for professional medical advice, diagnosis, or treatment. No medication, treatment, or change to your healthcare should be undertaken based on this content without first consulting a qualified doctor. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Consult Dr. Ruby Rashmi Specialist Obstetrician & Gynecologist, Dubai. Receive comprehensive evaluation and personalised treatment for heavy menstrual bleeding with evidence-based medical care and lifestyle guidance. Contact Us